Works in Cancer Chemotherapy & Pharmacology, 2013, Vol 71, Issue 4

Results: 34

Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.

Published in:

2013

By:

Cherian, Christina;
Kugel Desmoulin, Sita;
Wang, Lei;
Polin, Lisa;
White, Kathryn;
Kushner, Juiwanna;
Stout, Mark;
Hou, Zhanjun;
Gangjee, Aleem;
Matherly, Larry H

Publication type:

journal article

Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Published in:

2013

By:

Kang, Hye Jin;
Lee, Seung-Sook;
Byun, Byung Hyun;
Kim, Kyeong Min;
Lim, Ilhan;
Choi, Chang Woon;
Suh, Cheolwon;
Kim, Won Seog;
Nam, Seung-Hyun;
Lee, Soon Il;
Eom, Hyeon Seok;
Shin, Dong-Yeop;
Lim, Sang Moo

Publication type:

journal article

Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1073, doi. 10.1007/s00280-013-2103-3

By:

Wang, Shizhi;
Chen, Lulu;
Zhao, Qinghong;
Rong, Huan;
Wang, Meilin;
Gong, Weida;
Zhou, Jianwei;
Wu, Dongmei;
Zhang, Zhengdong

Publication type:

Article

A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 973, doi. 10.1007/s00280-013-2090-4

By:

Sasaki, Takashi;
Isayama, Hiroyuki;
Nakai, Yousuke;
Ito, Yukiko;
Yasuda, Ichiro;
Toda, Nobuo;
Kogure, Hirofumi;
Hanada, Keiji;
Maguchi, Hiroyuki;
Sasahira, Naoki;
Kamada, Hideki;
Mukai, Tsuyoshi;
Okabe, Yoshihiro;
Hasebe, Osamu;
Maetani, Iruru;
Koike, Kazuhiko

Publication type:

Article

Erratum to: Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic-phase chronic myeloid leukemia.

Published in:

2013

By:

Hsyu, Poe-Hirr;
Mould, Diane;
Upton, Richard;
Amantea, Michael

Publication type:

Correction Notice

Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 853, doi. 10.1007/s00280-013-2076-2

By:

Miyazaki, Tatsuya;
Sohda, Makoto;
Tanaka, Naritaka;
Suzuki, Shigemasa;
Ieta, Keisuke;
Sakai, Makoto;
Sano, Akihiko;
Yokobori, Takehiko;
Inose, Takanori;
Nakajima, Masanobu;
Fukuchi, Minoru;
Ojima, Hitoshi;
Kato, Hiroyuki;
Kuwano, Hiroyuki

Publication type:

Article

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 905, doi. 10.1007/s00280-013-2081-5

By:

Wang, Jialei;
Chang, Jianhua;
Yu, Hui;
Wu, Xianghua;
Wang, Huijie;
Li, Wenhua;
Ji, Dongmei;
Peng, Wei

Publication type:

Article

Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1033, doi. 10.1007/s00280-013-2098-9

By:

Park, Joo;
Lee, Soon;
Kim, Hye;
Kang, Sung;
Ko, Young;
Kim, Seung;
Kang, Seok;
Park, Young;
Choi, In;
Oh, Sang;
Sung, Deuk;
Seo, Jae;
Cheon, Jun;
Kim, Yeul;
Kim, Jun;
Park, Kyong

Publication type:

Article

A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1013, doi. 10.1007/s00280-013-2095-z

By:

Faivre, C.;
Barbolosi, D.;
Pasquier, E.;
André, N.

Publication type:

Article

A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 991, doi. 10.1007/s00280-013-2092-2

By:

Fujiwara, Yutaka;
Ando, Yuichi;
Mukohara, Toru;
Kiyota, Naomi;
Chayahara, Naoko;
Mitsuma, Ayako;
Inada-Inoue, Megumi;
Sawaki, Masataka;
Ilaria, Robert;
Kellie Turner, P.;
Funai, Jumpei;
Maeda, Kaijiro;
Minami, Hironobu

Publication type:

Article

Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 829, doi. 10.1007/s00280-012-2043-3

By:

Burris, Howard

Publication type:

Article

Repeated radioimmunotherapy with I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 945, doi. 10.1007/s00280-013-2087-z

By:

Kang, Hye;
Lee, Seung-Sook;
Byun, Byung;
Kim, Kyeong;
Lim, Ilhan;
Choi, Chang;
Suh, Cheolwon;
Kim, Won;
Nam, Seung-Hyun;
Lee, Soon;
Eom, Hyeon;
Shin, Dong-Yeop;
Lim, Sang

Publication type:

Article

A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 955, doi. 10.1007/s00280-013-2088-y

By:

Tsimberidou, Apostolia;
Ye, Yang;
Wheler, Jennifer;
Naing, Aung;
Hong, David;
Nwosu, Uchechi;
Hess, Kenneth;
Wolff, Robert

Publication type:

Article

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 913, doi. 10.1007/s00280-013-2082-4

By:

Tawfik, Hesham;
Rostom, Yousri;
Elghazaly, Hesham

Publication type:

Article

Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 859, doi. 10.1007/s00280-013-2077-1

By:

Kiyota, Hidemi;
Okamoto, Isamu;
Takeda, Masayuki;
Daga, Haruko;
Naito, Tateaki;
Miyazaki, Masaki;
Okada, Hideaki;
Hayashi, Hidetoshi;
Tanaka, Kaoru;
Terashima, Masaaki;
Azuma, Koichi;
Murakami, Haruyasu;
Takeda, Koji;
Yamamoto, Nobuyuki;
Nakagawa, Kazuhiko

Publication type:

Article

Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 893, doi. 10.1007/s00280-013-2080-6

By:

Du, Gangjun;
Yang, Yingming;
Zhang, Yaping;
Sun, Ting;
Liu, Weijie;
Wang, Yingying;
Li, Jiahuan;
Zhang, Houyun

Publication type:

Article

Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 921, doi. 10.1007/s00280-013-2083-3

By:

Chen, Liqi;
Li, Guoli;
Li, Jieshou;
Fan, Chaogang;
Xu, Jian;
Wu, Bo;
Liu, Kun;
Zhang, Caihua

Publication type:

Article

An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 867, doi. 10.1007/s00280-013-2078-0

By:

De, Pradip;
Dey, Nandini;
Terakedis, Breanne;
Bergsagel, P.;
Li, Zhi;
Mahadevan, Daruka;
Garlich, Joseph;
Trudel, Suzanne;
Makale, Milan;
Durden, Donald

Publication type:

Article

Genetic basis for the increased expression of vacuolar H translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1095, doi. 10.1007/s00280-013-2110-4

By:

Kulkarni, Hemant;
Göring, Harald;
Curran, Joanne;
Diego, Vincent;
Dyer, Thomas;
Cole, Shelley;
Walder, Ken;
Collier, Greg;
Blangero, John;
Carless, Melanie

Publication type:

Article

Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3- d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 999, doi. 10.1007/s00280-013-2094-0

By:

Cherian, Christina;
Kugel Desmoulin, Sita;
Wang, Lei;
Polin, Lisa;
White, Kathryn;
Kushner, Juiwanna;
Stout, Mark;
Hou, Zhanjun;
Gangjee, Aleem;
Matherly, Larry

Publication type:

Article

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 981, doi. 10.1007/s00280-013-2091-3

By:

Park, Sook;
Speranza, Giovanna;
Piekarz, Richard;
Wright, John;
Kinders, Robert;
Wang, Lihua;
Pfister, Thomas;
Trepel, Jane;
Lee, Min-Jung;
Alarcon, Sylvia;
Steinberg, Seth;
Collins, Jerry;
Doroshow, James;
Kummar, Shivaani

Publication type:

Article

The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 929, doi. 10.1007/s00280-013-2084-2

By:

Grommes, Christian;
Karlo, J.;
Caprariello, Andrew;
Blankenship, D'Arbra;
DeChant, Anne;
Landreth, Gary

Publication type:

Article

A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 883, doi. 10.1007/s00280-013-2079-z

By:

Antonarakis, Emmanuel;
Heath, Elisabeth;
Posadas, Edwin;
Yu, Evan;
Harrison, Michael;
Bruce, Justine;
Cho, Steve;
Wilding, Gregory;
Fetterly, Gerald;
Hangauer, David;
Kwan, Min-Fun;
Dyster, Lyn;
Carducci, Michael

Publication type:

Article

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 843, doi. 10.1007/s00280-013-2075-3

By:

Lee, Kyung-Hun;
Chang, Hye;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Bang, Yung-Jue;
Kim, Sun;
Lee, Keun-Wook;
Kim, Jee;
Hong, Yong;
Kim, Tae;
Park, Young;
Kang, Won;
Shin, Sang;
Ahn, Joong;
Kang, Gyeong;
Jeong, Seung-Yong;
Park, Kyu;
Park, Jae-Gahb;
Kim, Tae-You

Publication type:

Article

Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.

Published in:

2013

By:

Cheng, Ching-Yuan;
Cherng, Shur-Hueih;
Wu, Wen-Jun;
Yang, Tsung-Ying;
Huang, Xin-Yi;
Liao, Fu-Tien;
Wu, Ming-Fang;
Sheu, Gwo-Tarng

Publication type:

Letter

Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 937, doi. 10.1007/s00280-013-2086-0

By:

Shigeyasu, Kunitoshi;
Kagawa, Shunsuke;
Uno, Futoshi;
Nishizaki, Masahiko;
Kishimoto, Hiroyuki;
Gochi, Akira;
Kimura, Toshikazu;
Takahata, Takaomi;
Nonaka, Yasuyuki;
Ninomiya, Motoki;
Fujiwara, Toshiyoshi

Publication type:

Article

Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1059, doi. 10.1007/s00280-013-2101-5

By:

Harada, Hiroyuki;
Omura, Ken;
Tomioka, Hirofumi;
Nakayama, Hideki;
Hiraki, Akimitsu;
Shinohara, Masanori;
Yoshihama, Yasuto;
Shintani, Satoru

Publication type:

Article

Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors.

Published in:

2013

By:

Chen, Nianhang;
Chawla, Sant;
Chiorean, Elena;
Read, William;
Gorbaty, Mayer;
Mita, Alain;
Yung, Lotus;
Bryan, Peter;
McNally, Richard;
Renschler, Markus;
Sharma, Sunil

Publication type:

Report

Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 965, doi. 10.1007/s00280-013-2089-x

By:

Pham, Huyen;
Schwartz, Benjamin;
Delmore, James;
Reed, Eddie;
Cruickshank, Scott;
Drummond, Leanne;
Rodgers, Kathleen;
Peterson, Kainoa;
diZerega, Gere

Publication type:

Article

Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1021, doi. 10.1007/s00280-013-2097-x

By:

Kendrew, Jane;
Odedra, Rajesh;
Logié, Armelle;
Taylor, Paula;
Pearsall, Sharon;
Ogilvie, Donald;
Wedge, Stephen;
Jürgensmeier, Juliane

Publication type:

Article

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1065, doi. 10.1007/s00280-013-2102-4

By:

Zhang, Dong-sheng;
Wang, De-shen;
Wang, Zhi-qiang;
Wang, Feng-hua;
Luo, Hui-yan;
Qiu, Miao-zhen;
Wang, Feng;
Li, Yu-hong;
Xu, Rui-hua

Publication type:

Article

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1041, doi. 10.1007/s00280-013-2099-8

By:

Sandhu, Shahneen;
Papadopoulos, Kyri;
Fong, Peter;
Patnaik, Amita;
Messiou, Christina;
Olmos, David;
Wang, George;
Tromp, Brenda;
Puchalski, Thomas;
Balkwill, Frances;
Berns, Birge;
Seetharam, Shobha;
Bono, Johann;
Tolcher, Anthony

Publication type:

Article

The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1051, doi. 10.1007/s00280-013-2100-6

By:

Bisagni, G.;
Musolino, A.;
Panebianco, M.;
Matteis, A.;
Nuzzo, F.;
Ardizzoni, A.;
Gori, S.;
Gamucci, T.;
Passalacqua, R.;
Gnoni, R.;
Moretti, G.;
Boni, C.

Publication type:

Article

Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors.

Published in:

2013

By:

Kapoor, Shailendra

Publication type:

Letter